ArticleCardiovascular diabetology2016

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.

Takahiro Sawada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.